Oncology News | pharmaphorum

Thursday 30 April 2026

News

News

NHS funds BMS' Opdivo to prevent skin cancer returning

NHS funds BMS' Opdivo to prevent skin cancer returning

NICE has recommended interim NHS funding for Bristol-Myers Squibb’s cancer immunotherapy, Opdivo to prevent early stage skin cancer from recurring, overturning a decision earlier this year

News

Astellas scores first US blood cancer approval with Xospata

Astellas scores first US blood cancer approval with Xospata

The FDA has approved Astellas’ Xospata for certain patients with acute myeloid leukaemia – the company’s first drug approved in blood cancer.

News

NICE approves Bayer’s liver cancer drug

NICE approves Bayer’s liver cancer drug

NICE has given Bayer’s advanced liver cancer therapy Stivarga (regorafenib) the go-ahead after it undertook a rapid review following earlier guidance that rejected the drug.

News

EU approves Kyowa Kirin's drug for rare lymphoma

EU approves Kyowa Kirin's drug for rare lymphoma

The European Commission has approved Poteligeo (mogamulizumab), a treatment for rare types of non-Hodgkin’s lymphoma.

News

Bayer/Loxo drug approved in cancers with certain mutation

Bayer/Loxo drug approved in cancers with certain mutation

The FDA has approved Bayer and Loxo’s Vitrakvi (larotrectinib) for adults and children whose cancers have a specific genetic feature, or biomarker.

News

Cancer-cells-16-9

NHS lags best performers in cancer care - report

The performance of NHS cancer services in England is lagging behind those of comparable countries, according to a new report.